Your browser doesn't support javascript.
loading
Feedback from the 8th European Bioanalysis Forum Young Scientist Symposium.
Heughebaert, Liesl; Williams, Adam; Roberts, Amelia; Jacobs, Cathy; Szuster, Claire; Walker, Connor; Nuffel, Elien Van; Atkin, Esme; Minelli, Francesca; Groves, Kate; Sime, Katherine; Zeiser, Katia; Protti, Michele; Wagmann, Lea; Knight, Oscar; Stewart, Robert; Penford, Rosie; Calogero, Salvatore; Timmerman, Philip.
Affiliation
  • Heughebaert L; Laboratory of Toxicology, Ghent University, Ghent, 9000, Belgium.
  • Williams A; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, United Kingdom.
  • Roberts A; Bioanalytical Services, Quotient Sciences, Alnwick, NE66 2DH, United Kingdom.
  • Jacobs C; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany.
  • Szuster C; LC-MS Bioanalysis, Drug Development Solutions (part of Alliance Pharma), Fordham, CB7 5WW, United Kingdom.
  • Walker C; Roche Innovation Center Welwyn (contractor), Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom (employed by Quotient Sciences, Alnwick, NE66 2DH, United Kingdom, during the meeting).
  • Nuffel EV; Bioanalysis & Immunogenicity, DMPK, Sanofi, Zwijnaarde, 9052, Belgium.
  • Atkin E; Bioanalytical Services, ACM Global Laboratories, York, YO10 4DZ, United Kingdom.
  • Minelli F; R&D, New Biological Entities Drug Metabolism Pharmacokinetics, Innovative BioAnalytics, Merck KGaA, Colleretto Giacosa (TO), 10010, Italy.
  • Groves K; Translational Biomarker & Bioanalysis, UCB Biopharma SRL, Chemin du Foriest 1, Braine-l'Alleud, 1420, Belgium.
  • Sime K; Charles River Laboratories Edinburgh Ltd, Clearwater House, Research Avenue South, Edinburgh, EH14 4AS, United Kingdom.
  • Zeiser K; Bioanalysis, Nuvisan GmbH, Neu-Ulm, 89231, Germany.
  • Protti M; Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Department of Pharmacy & Biotechnology (FaBiT), Alma Mater Studiorum, University of Bologna, Bologna, 40127, Italy.
  • Wagmann L; Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany.
  • Knight O; Intertek Pharmaceutical Services, Manchester, M9 8GQ, United Kingdom.
  • Stewart R; Discovery Bioanalysis, Labcorp Early Development Laboratories Ltd, Harrogate, HG3 1PY, United Kingdom.
  • Penford R; Bioanalysis, Immunogenicity & Biomarkers, GSK, Stevenage, SG1 2NY, United Kingdom.
  • Calogero S; Biochemical Analysis, Swiss BioQuant, Reinach (BL), 4153, Switzerland (employed by F. Hoffmann-La Roche Ltd, Bioanalytical R&D, Regulated Bioanalysis, Basel, 4070, Switzerland, during the meeting).
  • Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium.
Bioanalysis ; 14(23): 1471-1477, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36734458
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Bioanalysis Year: 2022 Document type: Article Affiliation country: Belgium
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Bioanalysis Year: 2022 Document type: Article Affiliation country: Belgium